tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB
Holding MTNB?
Track your performance easily

Matinas BioPharma (MTNB) Financial Statements

1,518 Followers

Matinas BioPharma Financial Overview

Matinas BioPharma's market cap is currently ―. The company's EPS TTM is $-4.558; its P/E ratio is -0.12; Matinas BioPharma is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.27M$ -5.72M$ 5.98M$ -5.31M$ -6.13M
EBITDA$ -4.03M$ -5.51M$ 6.24M$ -5.06M$ -5.90M
Net Income Common Stockholders$ -4.28M$ -5.72M$ -5.82M$ -5.31M$ -6.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.79M$ 14.31M$ 8.11M$ 13.76M$ 18.22M
Total Assets$ 20.58M$ 24.36M$ 19.61M$ 25.10M$ 29.79M
Total Debt$ 3.07M$ 3.24M$ 3.40M$ 3.56M$ 3.71M
Net Debt$ -7.72M$ -11.07M$ -4.71M$ -10.20M$ -14.51M
Total Liabilities$ 4.80M$ 5.26M$ 5.05M$ 5.86M$ 6.64M
Stockholders Equity$ 15.78M$ 19.10M$ 14.56M$ 19.25M$ 23.15M
Cash Flow-
Free Cash Flow$ -3.50M$ -3.11M$ -5.77M$ -4.58M$ -4.43M
Operating Cash Flow$ -3.50M$ -3.11M$ -5.77M$ -4.58M$ -4.42M
Investing Cash Flow$ 9.65M$ -2.94M$ 2.00M$ 2.96M$ 1.08M
Financing Cash Flow$ -67.00K$ 9.19M$ 53.00K$ -1.00K$ -1.00K
Currency in USD

Matinas BioPharma Earnings and Revenue History

Matinas BioPharma Debt to Assets

Matinas BioPharma Cash Flow

Matinas BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis